Lyme Neuroborreliosis

CONTINUUM Lifelong Learning in Neurology

Volumn 21, Issue 6, 2015, Pages 1729-1744

  Marques, Adriana R ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BORRELIA BURGDORFERI; CLINICAL FEATURE; CRANIAL NEUROPATHY; DRUG EFFICACY; FACIAL NERVE PARALYSIS; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; LYME DISEASE; MENINGITIS; NEURITIS; NEUROLOGIC DISEASE; NEUROLOGIST; NONHUMAN; PARASITE SERODIAGNOSIS; REVIEW; UNITED STATES; LYME NEUROBORRELIOSIS; PATHOPHYSIOLOGY;

HUMANS; LYME NEUROBORRELIOSIS;

EID: 84949639464     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/CON.0000000000000252     Document Type: Review

References (54)

1. Mead PS. Epidemiology of Lyme disease. Infect Dis Clin North Am 2015;29(2):187-210. doi:10.1016/j.idc.2015.02.010.
2. des Vignes F, Piesman J, Heffernan R, et al. Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. J Infect Dis 2001;183(5):773-778.
3. Centers for Disease Control and Prevention. Reported Cases of Lyme Disease-United States, 2013. www.cdc.gov/lyme/stats/maps/map2013.html. Updated March 4, 2015. Accessed October 6, 2015.
4. Steere AC, Bartenhagen NH, Craft JE, et al. The early clinical manifestations of Lyme disease. Ann Intern Med 1983;99(1):76-82.
5. Nadelman RB, Nowakowski J, Forseter G, et al. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med 1996;100(5):502-508.
6. Strle F, Nadelman RB, Cimperman J, et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med 1999;130(1):32-36.
7. Nadelman RB. Erythema migrans. Infect Dis Clin North Am 2015;29(2):211-239. doi:10.1016/j.idc.2015.02.001.
8. Steere AC, Sikand VK. The presenting manifestations of Lyme disease and the outcomes of treatment. N Engl J Med 2003;348(24):2472-2474.
9. Kindstrand E, Nilsson BY, Hovmark A, et al. Peripheral neuropathy in acrodermatitis chronica atrophicans-a late Borrelia manifestation. Acta Neurol Scand 1997;95(6):338-345.
10. Halperin JJ, Logigian EL, Finkel MF, Pearl RA. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996;46(3):619-627.
11. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990;323(21):1438-1444.
12. Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med 1987;107(5):725-731.
13. Mullegger RR, Glatz M. Skin manifestations of lyme borreliosis: diagnosis andmanagement. Am J Clin Dermatol 2008;9(6):355-368. doi:10.2165/0128071-200809060-00002.
14. Halperin JJ. Nervous system Lyme disease. Infect Dis Clin North Am 2015;29(2):241-253. doi:10.1016/j.idc.2015.02.002.
15. Mygland A, Ljøstad U, Fingerle V, et al; European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010;17(1):8-16, e1-e4. doi:10.1111/j.1468-1331.2009.02862.x.
16. Reik L, Steere AC, Bartenhagen NH, et al. Neurologic abnormalities of Lyme disease. Medicine (Baltimore) 1979;58(4):281-294.
17. Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology 1985;35(1):47-53.
18. Halperin JJ, Pass HL, Anand AK, et al. Nervous system abnormalities in Lyme disease. Ann N Y Acad Sci 1988;539:24-34.
19. Belman AL, Iyer M, Coyle PK, Dattwyler R. Neurologic manifestations in children with North American Lyme disease. Neurology 1993;43(12):2609-2614.
20. Oschmann P, Dorndorf W, Hornig C, et al. Stages and syndromes of neuroborreliosis. J Neurol 1998;245(5):262-272.
21. Strle F, Ruzic-Sabljic E, Cimperman J, et al. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin Infect Dis 2006;43(6):704-710.
22. Halperin JJ. Facial nerve palsy associated with lyme disease. Muscle Nerve 2003;28(4):516-517.
23. Belman AL, Reynolds L, Preston T, et al. Cerebrospinal fluid findings in children with Lyme disease-associated facial nerve palsy. Arch Pediatr Adolesc Med 1997;151(12):1224-1228.
24. Sood SK. Lyme disease in children. Infect Dis Clin North Am 2015;29(2):281-294. doi:10.1016/j.idc.2015.02.011.
25. Avery RA, Frank G, Glutting JJ, Eppes SC. Prediction of Lyme meningitis in children from a Lyme disease-endemic region: a logistic-regression model using history, physical, and laboratory findings. Pediatrics 2006;117(1):e1-e7.
26. Garro AC, Rutman M, Simonsen K, et al. Prospective validation of a clinical prediction model for Lyme meningitis in children. Pediatrics 2009;123(5):e829-e834. doi:10.1542/peds.2008-2048.
27. Cohn KA, Thompson AD, Shah SS, et al. Validation of a clinical prediction rule to distinguish Lyme meningitis from aseptic meningitis. Pediatrics 2012;129(1):e46-e53. doi:10.1542/peds.2011-1215.
28. Halperin JJ, Krupp LB, Golightly MG, Volkman DJ. Lyme borreliosis-associated encephalopathy. Neurology 1990;40(9):1340-1343.
29. Kristoferitsch W, Sluga E, Graf M, et al. Neuropathy associated with acrodermatitis chronica atrophicans. Clinical and morphological features. Ann N Y Acad Sci 1988;539:35-45.
30. Halperin J, Luft BJ, Volkman DJ, Dattwyler RJ. Lyme neuroborreliosis. Peripheral nervous system manifestations. Brain 1990; 113(pt 4):1207-1221.
31. Marques AR. Laboratory diagnosis of Lyme disease: advances and challenges. Infect Dis Clin North Am 2015;29(2):295-307. doi:10.1016/j.idc.2015.02.005.
32. Centers for Disease Control and Prevention (CDC). Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995;44(31):590-591.
33. Steere AC, Berardi VP, Weeks KE, et al. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis 1990;161(6):1203-1209.
34. Ogrinc K, Lotric-Furlan S, Maraspin V, et al. Suspected early Lyme neuroborreliosis in patients with erythema migrans. Clin Infect Dis 2013;57(4):501-509. doi:10.1093/cid/cit317.
35. Djukic M, Schmidt-Samoa C, Lange P, et al. Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis. J Neurol 2012;259(4): 630-636. doi:10.1007/s00415-011-6221-8.
36. Stanek G, Lusa L, Ogrinc K, et al. Intrathecally produced IgG and IgM antibodies to recombinant VlsE, VlsE peptide, recombinant OspC and whole cell extracts in the diagnosis of Lyme neuroborreliosis. Med Microbiol Immunol 2013;203(2):125-132. doi:10.1007/s00430-013-0322-1.
37. Henningsson AJ, Christiansson M, Tjernberg I, et al. Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays. Eur J Clin Microbiol Infect Dis 2014;33(5): 797-803. doi:10.1007/s10096-013-2014-6.
38. van Burgel ND, Brandenburg A, Gerritsen HJ, et al. High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients. Clin Microbiol Infect 2011;17(10):1495-1500. doi:10.1111/j.1469-0691.2011.03459.x.
39. Cerar T, Ogrinc K, Lotric-Furlan S, et al. Diagnostic value of cytokines and chemokines in lyme neuroborreliosis. Clin Vaccine Immunol 2013;20(10):1578-1584. doi:10.1128/CVI.00353-13.
40. Cerar T, Ogrinc K, Strle F, Ruzic-Sabljic E. Humoral immune responses in patients with Lyme neuroborreliosis. Clin Vaccine Immunol 2010;17(4):645-650. doi:10.1128/CVI.00341-09.
41. Halperin JJ, Golightly M. Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group. Neurology 1992;42(7):1268-1270.
42. Smouha EE, Coyle PK, Shukri S. Facial nerve palsy in Lyme disease: evaluation of clinical diagnostic criteria. Am J Otol 1997;18(2):257-261.
43. Coyle PK, Schutzer SE, Deng Z, et al. Detection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme disease. Neurology 1995; 45(11):2010-2015. doi:10.1212/WNL.0b013e318211c39a.
44. Bremell D, Mattsson N, Edsbagge M, et al. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection. BMC Neurol 2013;13:2. doi:10.1186/1471-2377-13-2.
45. Schmidt C, Plate A, Angele B, et al. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology 2011;76(12): 1051-1058. doi:10.1212/WNL.0b013e318211c39a.
46. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43(9):1089-1134.
47. Halperin JJ, Shapiro ED, Logigian E, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007;69(1):91-102.
48. Logigian EL, Kaplan RF, Steere AC. Successful treatment of lyme encephalopathy with intravenous ceftriaxone. J Infect Dis 1999;180(2):377-383.
49. Marques A. Chronic Lyme disease: a review. Infect Dis Clin North Am 2008;22(2):341-360, vii-viii. doi:10.1016/j.idc.2007.12.011.
50. Feder HM Jr, Johnson BJ, O'Connell S, et al. A critical appraisal of ''chronic Lyme disease''. N Engl J Med 2007;357(14):1422-1430. doi:10.1056/NEJMra072023.
51. Luft BJ, Dattwyler RJ, Johnson RC, et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans: a double-blind, randomized, controlled trial. Ann Intern Med 1996;124(9):785-791.
52. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001;345(2):85-92.
53. Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 2003;60(12):1923-1930.
54. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 2008;70(13):992-1003.